SEI Investments
FULC icon

SEI Investments’s Fulcrum Therapeutics FULC Stock Holding History

SEI Investments’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
+30,681
New +$187K ﹤0.01% 3167
2026
Q1 		– Sell
-37,511
Closed -$424K – 3280
2025
Q4 		$424K Buy
+37,511
New +$382K ﹤0.01% 2583

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SEI Investments's FULC Position: Q2 2026 in Review

SEI Investments opened a new position in Fulcrum Therapeutics (FULC) in Q2 2026: 30,681 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #3167 among its holdings. This is a return to the name: SEI Investments previously reported a position in FULC as recently as Q4 2025.

SEI Investments first reported a position in FULC in Q4 2025 and has held it in 2 quarters since. The position peaked at $424K in Q4 2025. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • SEI Investments held 30,681 shares of Fulcrum Therapeutics worth $112K as of Q2 2026.
  • Fulcrum Therapeutics was a new SEI Investments position in Q2 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3167 holding.
  • SEI Investments first reported a position in Fulcrum Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • SEI Investments's Fulcrum Therapeutics position peaked at $424K in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.